-
Recognizing that patients and consumers are the key players in healthcare, all employees are recommended to spend 1% of their working hours with patients
-
We strive to improve access to medicines through the development and provision of innovative medicines.
-
May 18, 2020
-
May 14, 2020
EISAI TO PRESENT DATA ON ONCOLOGY PIPELINE AND PRODUCTS AT ASCO ANNUAL MEETING
-
April 27, 2020
-
April 1, 2020
-
March 26, 2020
-
May 26, 2020
-
May 15, 2020
-
May 14, 2020
IR “Annual Financial Results Briefing for the Fiscal Year Ended March 31, 2020 [Material, Webcast]”
-
May 13, 2020
IR “Annual Financial Report for the Fiscal Year Ended March 31, 2020”
-
March 9, 2020
-
February 14, 2020
EISAI TO VOLUNTARILY WITHDRAW ANTIOBESITY AGENT BELVIQ® / BELVIQ XR® IN THE U.S.
-
October 18, 2019
EISAI JOINS WORLD ECONOMIC FORUM AS STRATEGIC PARTNER ASSOCIATE
-
July 8, 2019
-
July 4, 2019
-
December 6, 2018
EISAI JOINS WORLD ECONOMIC FORUM CENTRE FOR THE FOURTH INDUSTRIAL REVOLUTION JAPAN
Eisai's hhc Philosophy
Sustainability
28 countries 2.0 billion tablets
Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of April 2020)
Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries
